1-52423946-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001009881.3(TUT4):c.4927G>T(p.Val1643Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001009881.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TUT4 | NM_001009881.3 | c.4927G>T | p.Val1643Leu | missense_variant | 30/30 | ENST00000257177.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TUT4 | ENST00000257177.9 | c.4927G>T | p.Val1643Leu | missense_variant | 30/30 | 1 | NM_001009881.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249754Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134930
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461020Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726698
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.4927G>T (p.V1643L) alteration is located in exon 30 (coding exon 29) of the ZCCHC11 gene. This alteration results from a G to T substitution at nucleotide position 4927, causing the valine (V) at amino acid position 1643 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at